May 3 Therapix Biosciences Ltd:
* Therapix Biosciences announces the appointment of Josh Blacher as chief financial officer
* Prior to joining Therapix, Blacher served as Chief Financial Officer at Galmed Pharmaceuticals Source text for Eikon: Further company coverage:
UPDATE 1-UK Stocks-Factors to watch on June 29
June 29 Britain's FTSE 100 index is seen opening up 37 points at 7,424 on Thursday, according to financial bookmakers, with futures up 0.52 percent ahead of the cash market open.
AstraZeneca, Chi-Med take kidney cancer drug into final testing
LONDON, June 29 AstraZeneca and Hutchison China MediTech said on Thursday they had initiated a global late-stage clinical trial of the experimental drug savolitinib in a relatively rare type of kidney cancer.